GOSH selects Cherwell for support in excluding bacterial spores from aseptic compounding

Cherwell Laboratories has recently supported the Great Ormond Street Hospital (GOSH) Pharmacy Unit in developing a new triple-wrapped prepared media product required to ensure the exclusion of bacterial spores during aseptic compounding validation.

This has, in turn, increased workflow efficiency within the unit by reducing false compounder system failures, as well as disinfection steps and use of toxic sporicidal sprays.

Validation of compounding in the hospital pharmacy is essential for demonstrating that appropriate controls are in place to ensure asepsis of the process and the sterility of filled products (e.g. parenteral nutrition), and ultimately, to ensure patient safety. In order to monitor the aseptic liquid transfer technique of compounder operators, GOSH routinely undertakes aseptic process simulation validation (media fill simulations) using tryptic soy broth (TSB). Following a series of media fill simulation failures by multiple operators, due to the contamination of filled TSB units with Bacillus species, an investigation to identify the cause was conducted by GOSH.

This investigation found that the contamination was not attributable to operator competency, as they had strictly adhered to NHS aseptic transfer process guidance [1].

The contamination source was ultimately identified to originate from the TSB medium bottle surfaces following storage in an uncontrolled environment.  No bacteria were recovered from the surface of large volume licensed medicinal products, confirming that risk of spore contamination was during media fill validation and not actual medicine compounding.

 

GOSH sought an alternative microbiological media supplier to develop a way of ensuring the TSB units for aseptic process simulation validation were sterile, and Cherwell Laboratories were invited to collaborate with GOSH on this project. To remedy the situation, Cherwell developed a sterile, triple packaged TSB product in line with Royal Pharmaceutical Society recommendations [2]. GOSH Pharmacists found this prototype was easy to use and removed the risk of spore contamination of the medium prior to compounder validation, thereby eliminating false results and ultimately increasing workflow efficiency in the Pharmacy Unit.

Following the collaboration, GOSH and Cherwell have jointly published a white paper and scientific poster detailing the investigation and development of the new multilayer packaging of bacteriological medium to prevent spore contamination prior to compounder validation. Both were presented at the recent Clinical Pharmacy Congress and are now available to download from Cherwell’s website.

More about Cherwell Laboratories

 

Other news

Upcoming Events

British Orthopaedic Association Century Congress

ICC Birmingham
25th - 28th September 2018

Infection Prevention 2018

Scottish Events Campus, Glasgow
30th September - 2nd October 2018

iM Med Study Day – Tuesday 9th October 2018

The Queens (Hotel) City Square
9th October 2018

IPS 8th Annual IV Forum Conference 2018

The Mercure Sheffield St Paul's Hotel
Tuesday 13th November

Medica 2018

DÜSSELDORF MESSE
12th - 15th November 2018

Latest Issue

Clinical Services Journal

Clinical Services Journal

Sep 2018

More than a wipes manufacturer

Register now to apply for regular copies of Clinical Services Journal and free access to premium content, as well as our regular newsletters.

CSJ Supplements

CSJ Supplements

Aug 2018

Sunoptic’s brightest LED headlight

Register now to apply for regular copies of CSJ Supplements and free access to premium content, as well as our regular newsletters.